Investigational antiviral drugs for the treatment of COVID-19

enthalten in: Drugs of the future | 2021

von Vegivinti, C. | Assi, M. | Talwani, R. | +3

Investigational immunomodulatory therapies for COVID-19

enthalten in: Drugs of the future | 2021

von Assi, M. | Koshy, K. | El Atrouni, W. | +4

Molnupiravir. RNA-directed RNA polymerase (RdRp) inhibitor, Treatment of mild to moderate COVID-19

enthalten in: Drugs of the future | 2021

von Kaul, G. | Dasgupta, A. | Chopra, S.

Repurposing approach of fluvoxamine for COVID-19

enthalten in: Drugs of the future | 2021

von McCarthy, M.

Remdesivir. RNA-dependent RNA polymerase inhibitor, Treatment of Ebola virus infection, Treatment of SARS-CoV-2 infection (COVID-19)

enthalten in: Drugs of the future | 2020

von Ahmad, M. | Dasgupta, A. | Chopra, S.

Taking aim at a fast-moving target: targets to watch for SARS-CoV-2 and COVID-19

enthalten in: Drugs of the future | 2020

von Sorbera, L. | Graul, A. | Dulsat, C.